Alimera Sciences, Flextronics enter manufacturing services agreement Alimera Sciences (ALIM) entered into a Manufacturing Services Agreement with Flextronics Medical Sales and Marketing. Under the Agreement, Flextronics (FLEX) will manufacture Alimera’s proprietary inserter system for use with ILUVIEN, Alimera’s sustained release intravitreal implant for the treatment of chronic diabetic macular edema. Under the Agreement, Alimera will pay certain per Product unit prices based on regularly scheduled shipments of a minimum number of Product units.
Flextronics upgraded to Neutral from Sell at Goldman Goldman Sachs upgraded Flextronics to Neutral on its belief the company's communications infrastructure revenue trends are bottoming. Goldman raised its price target for shares to $12 from $11.